Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022

被引：0

作者：

Surie, Diya ^{[1
]}

Bonnell, Levi ^{[1
]}

Adams, Katherine ^{[1
]}

Gaglani, Manjusha ^{[2
,3
]}

Ginde, Adit A. ^{[4
]}

Douin, David J. ^{[4
]}

Talbot, H. Keipp ^{[5
]}

Casey, Jonathan D. ^{[5
]}

Mohr, Nicholas M. ^{[6
]}

Zepeski, Anne ^{[6
]}

McNeal, Tresa ^{[3
,4
]}

Ghamande, Shekhar ^{[3
,4
]}

Gibbs, Kevin W. ^{[7
]}

Files, D. Clark ^{[7
]}

Hager, David N. ^{[8
]}

Shehu, Arber ^{[8
]}

Frosch, Anne P. ^{[9
]}

Erickson, Heidi L. ^{[9
]}

Gong, Michelle N. ^{[10
]}

Mohamed, Amira ^{[10
]}

Johnson, Nicholas J. ^{[11
]}

Srinivasan, Vasisht ^{[11
]}

Steingrub, Jay S. ^{[12
]}

Peltan, Ithan D. ^{[13
]}

Brown, Samuel M. ^{[13
]}

Martin, Emily T. ^{[14
]}

Khan, Akram ^{[15
]}

Bender, William S. ^{[16
]}

Duggal, Abhijit ^{[17
]}

Wilson, Jennifer G. ^{[18
]}

Qadir, Nida ^{[19
]}

Chang, Steven Y. ^{[19
]}

Mallow, Christopher ^{[20
]}

Rivas, Carolina ^{[20
]}

Kwon, Jennie H. ^{[21
]}

Exline, Matthew C. ^{[22
]}

Lauring, Adam S. ^{[23
]}

Shapiro, Nathan I. ^{[24
]}

Halasa, Natasha ^{[5
]}

Chappell, James D. ^{[5
]}

Grijalva, Carlos G. ^{[5
]}

Rice, Todd W. ^{[5
]}

Stubblefield, William B. ^{[5
]}

Baughman, Adrienne ^{[5
]}

Womack, Kelsey N. ^{[5
]}

Hart, Kimberly W. ^{[5
]}

Swan, Sydney A. ^{[5
]}

Zhu, Yuwei ^{[5
]}

DeCuir, Jennifer ^{[1
]}

Tenforde, Mark W. ^{[1
]}

机构：

[1] CDC COVID 19 Emergency Response Team, Atlanta, GA 30329 USA

[2] Baylor Scott & White Hlth, Temple, TX USA

[3] Texas A&M Univ, Coll Med, Temple, TX USA

[4] Univ Colorado, Sch Med, Aurora, CO USA

[5] Vanderbilt Univ Sch Med, Nashville, TN USA

[6] Univ Iowa, Iowa City, IA USA

[7] Wake Forest Univ, Baptist Med Ctr, Winston Salem, NC USA

[8] Johns Hopkins Univ Hosp, Baltimore, MD USA

[9] Hennepin Cty Med Ctr, Minneapolis, MN USA

[10] Albert Einstein Coll Med, Montefiore Healthcare Ctr, New York, NY USA

[11] Univ Washington, Sch Med, Seattle, WA USA

[12] Baystate Med Ctr, Springfield, MA USA

[13] Univ Utah, Intermt Med Ctr, Salt Lake City, UT USA

[14] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI USA

[15] Oregon Hlth & Sci Univ Hosp, Portland, OR USA

[16] Emory Univ, Sch Med, Atlanta, GA USA

[17] Cleveland Clin, Cleveland, OH USA

[18] Stanford Univ, Sch Med, Stanford, CA USA

[19] Ronald Reagan UCLAMed Ctr, Los Angeles, CA USA

[20] Univ Miami, Miami, FL USA

[21] Washington Univ, St Louis, MO USA

[22] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA

[23] Univ Michigan, Sch Med, Ann Arbor, MI USA

[24] Beth Israel Deaconess Med Ctr, Boston, MA USA

来源：

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT | 2022年 / 71卷 / 42期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：1327 / 1334

页数：8

共 46 条

[21] Neutralization of SARS-CoV-2 Omicron BA.1, BA.4, and BA.5 by primary ChAdOx1 nCoV-19, mRNA-1273, MVC-COV1901 and booster mRNA-1273 vaccination
Liu, Yuag-Meng
Lee, Yu-Lin
Liu, Chun-Eng
Chen, Yi-Chun
Tien, Ni
Su, Wen-Chi
INFECTION, 2023, 51 (02) : 531 - 534
[22] Neutralization of SARS-CoV-2 Omicron BA.1, BA.4, and BA.5 by primary ChAdOx1 nCoV-19, mRNA-1273, MVC-COV1901 and booster mRNA-1273 vaccination
Yuag-Meng Liu
Yu-Lin Lee
Chun-Eng Liu
Yi-Chun Chen
Ni Tien
Wen-Chi Su
Infection, 2023, 51 : 531 - 534
[23] Differences in Clinical Presentation of COVID-19 in Children Hospitalized During Domination of Early (BA.1, BA.2) and Late (BA.5, BA.2.75, BQ.1 and XBB.1.5) SARS-CoV-2 Omicron Subvariants
Pokorska-Spiewak, Maria
Pawlowska, Malgorzata
Ciechanowski, Przemyslaw
Peregrym, Michal
Dobrzeniecka, Anna
Sobolewska-Pilarczyk, Malgorzata
Franczak, Justyna
Majda-Stanislawska, Ewa
Szczepanska, Barbara
Zaleska, Izabela
Flisiak, Robert
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2024, 43 (02) : 149 - 154
[24] Comparative Effectiveness of the Bivalent (Original/Omicron BA.4/BA.5) mRNA COVID-19 Vaccines mRNA-1273.222 and BNT162b2 Bivalent in Adults with Underlying Medical Conditions in the United States
Kopel, Hagit
Nguyen, Van Hung
Bogdanov, Alina
Winer, Isabelle
Boileau, Catherine
Ducruet, Thierry
Zeng, Ni
Winer-Jones, Jessamine P.
Esposito, Daina B.
Bausch-Jurken, Mary
Beck, Ekkehard
Bonafede, Machaon
Mansi, James A.
VACCINES, 2024, 12 (10)
[25] SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine - Ohio and Rhode Island, September-November 2022
Canaday, David H.
Oyebanji, Oladayo A.
White, Elizabeth M.
Bosch, Jurgen
Nugent, Clare
Vishnepolskiy, Igor
Abul, Yasin
Didion, Elise M.
Paxitzis, Alexandra
Sundheimer, Nicholas
Ragavapuram, Vaishnavi
Wilk, Dennis
Keresztesy, Debbie
Cao, Yi
St Denis, Kerri
McConeghy, Kevin W.
McDonald, L. Clifford
Jernigan, John A.
Mylonakis, Eleftherios
Wilson, Brigid M.
King, Christopher L.
Balazs, Alejandro B.
Gravenstein, Stefan
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (04): : 100 - 106
[26] COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA. 2 subvariants - surveillance results from southern Sweden, December 2021 to March 2022
Bjork, Jonas
Bonander, Carl
Moghaddassi, Mahnaz
Rasmussen, Magnus
Malmqvist, Ulf
Inghammar, Malin
Kahn, Fredrik
EUROSURVEILLANCE, 2022, 27 (18) : 8 - 13
[27] COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history
Townsley, Hermaleigh
Gahir, Joshua
Russell, Timothy W.
Greenwood, David
Carr, Edward J.
Dyke, Matala
Adams, Lorin
Miah, Murad
Clayton, Bobbi
Smith, Callie
Miranda, Mauro
Mears, Harriet V.
Bailey, Chris
Black, James R. M.
Fowler, Ashley S.
Crawford, Margaret
Wilkinson, Katalin
Hutchinson, Matthew
Harvey, Ruth
O'Reilly, Nicola
Kelly, Gavin
Goldstone, Robert
Beale, Rupert
Papineni, Padmasayee
Corrah, Tumena
Gilson, Richard
Caidan, Simon
Nicod, Jerome
Gamblin, Steve
Kassiotis, George
Libri, Vincenzo
Williams, Bryan
Gandhi, Sonia
Kucharski, Adam J.
Swanton, Charles
Bauer, David L. V.
Wall, Emma C.
PLOS ONE, 2024, 19 (03):
[28] Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022
Veneti, Lamprini
Boas, Hakon
Kristoffersen, Anja Brathen
Stalcrantz, Jeanette
Bragstad, Karoline
Hungnes, Olav
Storm, Margrethe Larsdatter
Aasand, Nina
Ro, Gunnar
Starrfelt, Jostein
Seppala, Elina
Kvale, Reidar
Vold, Line
Nygard, Karin
Buanes, Eirik Alnes
Whittaker, Robert
EUROSURVEILLANCE, 2022, 27 (04)
[29] Longitudinal data on humoral response and neutralizing antibodies against SARS-CoV-2 Omicron BA.1 and subvariants BA.4/5 and BQ.1.1 after COVID-19 vaccination in cancer patients
Oliver Overheu
Simon Lendowski
Daniel R. Quast
Daniel Kühn
Elena Vidal Blanco
Anna-Lena Kraeft
Eike Steinmann
Eleni Kourti
Celine Lugnier
Joerg Steinmann
Anke Reinacher-Schick
Stephanie Pfaender
Journal of Cancer Research and Clinical Oncology, 2023, 149 : 10633 - 10644
[30] Longitudinal data on humoral response and neutralizing antibodies against SARS-CoV-2 Omicron BA.1 and subvariants BA.4/5 and BQ.1.1 after COVID-19 vaccination in cancer patients
Overheu, Oliver
Lendowski, Simon
Quast, Daniel R.
Kuehn, Daniel
Blanco, Elena Vidal
Kraeft, Anna-Lena
Steinmann, Eike
Kourti, Eleni
Lugnier, Celine
Steinmann, Joerg
Reinacher-Schick, Anke
Pfaender, Stephanie
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10633 - 10644

← 1 2 3 4 5 →